FDA: Pharmaceutical Cheerios?
I did not realize there were negative side effects or addiction problems with Cheerios but apparently the FDA thinks Cheerios are…
Monthly Publications
In Depth
Subscribe Now
In Depth
coverage of timely
Life Science
Compliance issues
Subscribe Now
Monthly Archives
May 2009
FDA: Presenting Risk Information in Prescription Drug and Medical Device…
This week, the U.S Food and Drug Administration (FDA) issued a draft Guidance for Industry titled "Presenting Risk Information…
FDA: Presenting Risk Information in Prescription Drug and Medical Device…
The Coalition for Healthcare Communication will be filing extensive comments on the FDA draft Guidance and solicits your…
APA: Proposes Guidelines for Members
This past week at the APA Annual Meeting, they held a session proposing new ethical guidelines for their association and members.…
Health Care Reform: Orszag Back on the Trial
In today’s Bloomberg is an article on Peter Orszag Director of the Office of Management and Budget (OMB) and his passion for…
ACCME Calls for Comment May 2009 – Reconsideration
In April, the Accreditation Council on Continuing Medical Education (ACCME) issued a call for comments in four areas:
Rule…
Memorial Day 2009
With America at war in Iraq and Afghanistan, Memorial Day is a day to remember those who sacrificed their lives for our freedom.…
Health Care Convention and Exhibitors Association Annual Meeting
For those readers who follow closely health care conventions and the rules around exhibits, the Health Care Convention and…
AMA CEJA: Council on Medical Education (CME) Conflict of Interest and Bias…
In addition to the CEJA Report the AMA Council on Medical Education (The Council) issued proposed guidelines for CME providers,…
Health Care Reform: Orszag – Baucus Financing on the Backs of the Insured
This week Peter R. Orszag, director of the Whitehouse Office of Budget and Management (OMB) has been making statements on…